Navigation Links
STAAR Surgical Announces Second Quarter 2013 Results Release Date And Conference Call And Webcast

MONROVIA, Calif., July 18, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) today announced that it will release its financial results for the second quarter ended June 28, 2013 on Wednesday, July 31, 2013 after the market close.  The Company will host a conference call and webcast on Wednesday, July 31, 2013 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the Company's second quarter results and recent corporate developments. The dial-in number for the conference call is 877-703-6105 for domestic participants and 857-244-7304 for international participants, both using the passcode 23510067.

The Company will also be using slides to illustrate its second quarter results and operational progress.  The slides and live webcast of the call can be accessed from the investor relations section of the STAAR website at taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days.  This replay can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers, both using passcode 40120994  An archived webcast will also be available at

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 350,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.  CONTACT: 

InvestorsMediaEVC Group

EVC GroupLeigh Salvo

Chris GaleDoug Sherk


SOURCE STAAR Surgical Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical To Present At Upcoming Investor Conferences
2. STAAR Surgical Reports Strong First Quarter 2013 Financial Results
3. STAAR Surgical Provides Preliminary First Quarter Revenue Results
4. STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
5. STAAR Surgical Reports Third Quarter 2012 Financial Results
6. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
7. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
8. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
9. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
10. STAAR Surgical Reports Second Quarter 2012 Financial Results
11. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
Post Your Comments:
(Date:11/24/2015)... , November 25, 2015 The ... to repeated failure of IVF cycles. After failure of ... dejected and had lost all hopes that she would be able to ... miracle child conceived after failure of over 15 IVF ... (UK) before they decided to take one last attempt with Gaudium ...
(Date:11/24/2015)... CARLOS, Calif. , Nov. 24, 2015 ... a leader in non-invasive genetic testing and ... announced that it will present at the ... in New York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew ... the Company,s financial results, business activities and ...
(Date:11/24/2015)... TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ - ... NASDAQ: EPIX ) announced today that the first ... study of EPI-506 as a treatment for metastatic castration-resistant ... and Canada.  --> ... --> In the Phase 1/2 clinical trial, ESSA ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk ... roadways has dropped below 10,000 for the first time since 2011. In 2014, there ... According to data released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people ...
(Date:11/25/2015)... ... ... An unlikely combination of recycled plastic shopping bags in ... to have a more dignified and comfortable night’s sleep. , Residents of Friendship ... bags into sleeping mats for the homeless. The project, according to Jeannette ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... bunion treatment, is offering lower prices in an early celebration of the early ... the promotional price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing ...
(Date:11/24/2015)... ... November 24, 2015 , ... Young patients with a wide variety ... Wolfman and Dr. Kedar S. Lele, who are pediatric dentists in Tucson, AZ ... the WaterLase iPlus 2.0™ system causes minimal discomfort and bleeding to the patient during ...
(Date:11/24/2015)... ... , ... DMG Productions announced that they will feature Aphria, Inc., in an ... Channel. Dates and show times TBA. , Aphria, Inc., is a publicly traded company ... and supplying medical marijuana pursuant to the Marijuana for Medical Purposes Regulations (the “MMPR”). ...
Breaking Medicine News(10 mins):